Insulin-like growth factor-I (
IGF-I) is widely expressed in the central nervous system (CNS). Whereas during normal development
IGF-I is expressed predominantly by neurons and to a much lesser degree by glial cells, its expression in astrocytes, and often in microglia, is increased during and/or after variety of CNS
injuries. Recently we have generated a new line of
IGF-I Tg mice, called
IGF-I(Ast/Tet-Off) Tg mice, in which
IGF-I transgene is expressed specifically in astrocytes and is tightly controlled by the
tetracycline analog
doxycycline. In this study we examined whether
IGF-I derived from astrocytes is capable of promoting neural cell growth during development. When the
IGF-I transgene is allowed to be expressed,
IGF-I(Ast/Tet-Off) Tg mice exhibit markedly increases in 1) brain weight; 2) brain
DNA and
protein abundance; and 3) number of neurons, oligodendrocytes, and astrocytes, as well as myelination, findings similar to those observed in our other lines of Tg mice that express
IGF-I transgene predominantly in neurons. Unlike Tg mice with neuron-specific
IGF-I expression, which manifest marked increases in the concentrations of oligodendrocyte/myelin-specific
proteins, however,
IGF-I(Ast/Tet-Off) Tg mice exhibit an increase in the concentration of
glial fibrillary acidic protein, an astrocyte-specific
protein. Furthermore, when transgene expression is blunted, brain overgrowth in
IGF-I(Ast/Tet-Off) Tg mice ceases. Our data indicate that astrocyte-derived
IGF-I is capable of promoting neural cells growth in vivo. Our data also suggest that
IGF-I's actions in CNS depend in part on the location of its expression and cellular microenvironment and that continuous presence of
IGF-I expression is necessary for brain overgrowth.